Compare Heron Therapeutics Inc (HRTX) vs BlackRock TCP Capital Corp (TCPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs BlackRock TCP Capital Corp — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while BlackRock TCP Capital Corp trades at $3.94 (market cap $327.64M). The key difference: BlackRock TCP Capital Corp is far larger — about 5.3× Heron Therapeutics Inc's market cap, and BlackRock TCP Capital Corp pays a 19.46% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | TCPC | |
|---|---|---|
Market Cap | $61.47M | $327.64M |
Sector | Health | Financials |
52-Week High | $1.49 | $7.26 |
52-Week Low | $0.32 | $3.13 |
Enterprise Value | $168.21M | — |
Dividend Yield | — | 19.46% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About BlackRock TCP Capital Corp
BlackRock TCP Capital Corp is a finance company specializing in middle-market lending. It aims for high returns through income and capital appreciation while prioritizing principal protection. The company invests in debt securities and earns revenue from interest payments, fees, and some equity appreciation.
Read more on TCPC →
